Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-025362

Chief Executive Officer sold 14,683 shares at $231.91 ($3,405,206)

  • Chief Executive Officer acquired 14,683 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Farrell Michael J. Chief Executive Officer 2024-10-07 Option exercise 10b5-1 +14,683 $84.98 $1,247,761 478,852 D
Farrell Michael J. Chief Executive Officer 2024-10-07 Sale 10b5-1 −14,683 $231.91 $3,405,206 464,169 D
Derivatives
Farrell Michael J. Chief Executive Officer 2024-10-07 Option exercise · ResMed Common Stock Options 10b5-1 −14,683 14,683 D
Open-market sales · 14,683 sh · avg $231.91 · $3,405,206
Loading xslF345X05/form4.xml…